We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+12.83%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$63.1B
AUM Growth
+$3.79B
Cap. Flow
-$1.12B
Cap. Flow %
-1.77%
Top 10 Hldgs %
32.11%
Holding
999
New
156
Increased
303
Reduced
370
Closed
127

Top Sells

Rank Stock Value
1
HES
Hess
HES
+$1.35B
2
INSM icon
Insmed
INSM
+$197M
3
HUBB icon
Hubbell
HUBB
+$191M
4
ARGX icon
argenx
ARGX
+$164M
5
SLNO
Soleno Therapeutics
SLNO
+$161M

Sector Composition

Rank Sector Weight
1 Technology 30.31%
2 Healthcare 13.97%
3 Financials 11.89%
4 Consumer Discretionary 9.55%
5 Communication Services 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GEV icon
76
GE Vernova
GEV
$271B
$148M 0.23%
240,499
+4,500
+2% +$2.73M
SRE icon
77
Sempra
SRE
$56.6B
$148M 0.23%
1,643,370
+1,046,000
+175% +$84.7M
LOW icon
78
Lowe's Companies
LOW
$122B
$142M 0.22%
563,105
+266,700
+90% +$65.5M
CVS icon
79
CVS Health
CVS
$133B
$141M 0.22%
1,871,399
+261,800
+16% +$17.9M
BLK icon
80
Blackrock
BLK
$175B
$141M 0.22%
120,980
-3,400
-3% -$3.8M
BKNG icon
81
Booking.com
BKNG
$151B
$140M 0.22%
647,500
-33,750
-5% -$7.53M
ISRG icon
82
Intuitive Surgical
ISRG
$130B
$139M 0.22%
310,983
-58,601
-16% -$28.1M
AXP icon
83
American Express
AXP
$234B
$139M 0.22%
418,088
+6,700
+2% +$2.13M
CYBR
84
DELISTED
CyberArk
CYBR
$139M 0.22%
+287,232
New +$123M
TXN icon
85
Texas Instruments
TXN
$259B
$139M 0.22%
754,144
+19,700
+3% +$3.85M
AMAT icon
86
Applied Materials
AMAT
$434B
$137M 0.22%
669,726
-136,400
-17% -$24.7M
SPGI icon
87
S&P Global
SPGI
$122B
$137M 0.22%
280,720
-47,300
-14% -$25.3M
ACN icon
88
Accenture
ACN
$104B
$135M 0.21%
546,422
+23,000
+4% +$6M
INTC icon
89
Intel
INTC
$509B
$135M 0.21%
4,015,285
+20,100
+0.5% +$487K
APH icon
90
Amphenol
APH
$211B
$135M 0.21%
1,087,720
-12,700
-1% -$1.39M
RTX icon
91
RTX Corp
RTX
$294B
$134M 0.21%
801,035
-327,522
-29% -$50.8M
MTDR icon
92
Matador Resources
MTDR
$6.06B
$134M 0.21%
2,980,997
+424,525
+17% +$20.7M
ETNB
93
DELISTED
89bio
ETNB
$134M 0.21%
9,097,587
+7,128,587
+362% +$72.7M
BSX icon
94
Boston Scientific
BSX
$71.1B
$132M 0.21%
1,347,416
-707,949
-34% -$73.3M
ANET icon
95
Arista Networks
ANET
$240B
$131M 0.21%
897,200
+29,000
+3% +$3.73M
ADBE icon
96
Adobe
ADBE
$102B
$129M 0.2%
365,778
+3,900
+1% +$1.4M
PRAX icon
97
Praxis Precision Medicines
PRAX
$8.64B
$126M 0.2%
2,374,085
+399,500
+20% +$19.4M
GD icon
98
General Dynamics
GD
$104B
$122M 0.19%
359,215
+108,979
+44% +$34.3M
WM icon
99
Waste Management
WM
$90B
$122M 0.19%
552,892
-163,784
-23% -$36.9M
VTR icon
100
Ventas
VTR
$46.6B
$120M 0.19%
1,719,700
-24,600
-1% -$1.65M

Similar funds

Adage Capital Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Adage Capital Partners held 999 positions worth $63.1B, up 6.4% from $59.3B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Adage Capital Partners's Q3 2025 filing shows 156 new, 303 increased, 370 reduced and 127 closed positions. Its largest new stake was Chevron: 3,284,841 shares worth $510M. The largest sale was Hess, an estimated $1.35B.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q3 2025 buy was Chevron: 3,284,841 shares worth $510M.
  • Adage Capital Partners added most to Royalty Pharma in Q3 2025, an estimated $216M increase.
  • Adage Capital Partners's biggest Q3 2025 reduction was Insmed, cutting an estimated $197M.
  • Adage Capital Partners fully exited Hess in Q3 2025, selling an estimated $1.35B.
  • Adage Capital Partners's ten largest holdings make up 32% of its $63.1B portfolio in Q3 2025.
  • Adage Capital Partners opened 156 new positions and closed 127 in Q3 2025.
  • Adage Capital Partners's portfolio value rose 6.4% quarter-over-quarter to $63.1B.

Based on Adage Capital Partners's 13F filing for Q3 2025, filed 14 Nov 2025.